Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System

Published:2019-05-08 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Barcelos Flávia Campos,Matos Guacira Corrêa de,Silva Mario Jorge Sobreira da,Silva Fabrício Alves Barbosa da,Lima Elisangela da Costa

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Methods for safety signal detection in healthcare databases: a literature review;Arnaud;Expert Opin. Drug Saf.,2017

2. Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs;Arora;Ther. Clin. Risk Manag.,2017

3. Pharmacovigilance in oncology: evaluation of current practice and future perspectives;Baldo;J. Eval. Clin. Pract.,2014

4. Caring for the treatment-experienced breast cancer patient: the phrmacist‘s role;Barbour;Am. J. Health Syst. Pharm.,2008

5. Quantitative signal detection using spontaneous ADR reporting;Bate;Pharmacoedidemiol. Drug Saf.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-marketing safety concerns with elagolix: a disproportionality analysis of the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-05-07

2. Exploring of a Potential Breast Cancer Based on Isoxazole Derivatives: An Integrated In-Silico Methods;2024

3. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions;European Journal of Clinical Pharmacology;2023-12-15

4. Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow);Frontiers in Pharmacology;2022-09-20

5. Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study;Frontiers in Pharmacology;2022-01-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3